EcoDrugPlus

Atp-Binding Cassette Sub-Family C Member 9-Like

Ensembl ID : ENSSTUG00000042569
Gene Symbol: LOC115179981
3 Cross references
219 Possible Orthologues:

Atp-Binding Cassette Sub-Family C Member 9-Like

Ensembl ID : ENSSTUG00000003505
Gene Symbol: LOC115199180
3 Cross references
222 Possible Orthologues:

Atp-Sensitive Inward Rectifier Potassium Channel 11-Like

Ensembl ID : ENSSTUG00000016295
Gene Symbol: LOC115197050
3 Cross references
183 Possible Orthologues:

Atp-Sensitive Inward Rectifier Potassium Channel 11-Like

Ensembl ID : ENSSTUG00000022451
Gene Symbol: LOC115192775
3 Cross references
182 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSSTUG00000017972
Gene Symbol: ATP4A
3 Cross references
175 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSSTUG00000008706
Gene Symbol: ATP4A
3 Cross references
173 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSSTUG00000034422
Gene Symbol: ATP4B
3 Cross references
183 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSSTUG00000032984
Gene Symbol: ATP4B
3 Cross references
183 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSSTUG00000029980
Gene Symbol: ATP1A1
3 Cross references
149 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSSTUG00000026430
Gene Symbol: ATP1A1
3 Cross references
145 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSSTUG00000001718
Gene Symbol: ATP1A1
3 Cross references
211 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSSTUG00000001428
Gene Symbol: ATP1A1
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).